Research Insight
The diabetes drug pioglitazone is associated with an increased risk of bladder cancer
The diabetes drug pioglitazone is associated with an increased risk of bladder cancer, finds a study published by The BMJ today. The findings suggest...
Press Releases
Proteostasis Therapeutics, Inc. Presents New Data Demonstrating Potential for Genotype-Agnostic and Combination Therapies for People with Cystic Fibrosis
Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing. ...
Press Releases
ASLAN Pharmaceuticals named Asian Biotech of the year
ASLAN Pharmaceuticals (ASLAN), a biotech company focused on the development of immunotherapies and targeted agents for Asia prevalent tumour types, has been named ‘Asian...
News
Covance announces mobile health solutions to support use of mobile technology in clinical trials
Laboratory Corporation of America® Holdings announced that Covance Drug Development (Covance) has launched Mobile Health Solutions, a suite of new capabilities designed to help...
Press Releases
FDA Grants Genentech’s Cancer Immunotherapy Atezolizumab Priority Review for Advanced Bladder Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted...
Press Releases
Quintiles and the American College of Surgeons Announce Agreement to Develop Clinical Registry of the Future
Quintiles and the American College of Surgeons (ACS) today announced a six-year strategic services agreement to improve data collection and quality reporting for all...
Press Releases
Amgen Wins Patent Case On Repatha
Amgen announced that a Delaware jury delivered a verdict in Amgen's favor in a trial on the validity of two Amgen patents that describe...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read